Results 21 to 30 of about 5,458,526 (247)
AMAN (ALLIANCE OF NUSANTARA INDIGENOUS PEOPLE) PUBLIC RELATIONS COMMUNICATION IN THE COVID-19 VACCINE PRIORITY PROGRAM [PDF]
, 2022 Public relations in practice has a relationship with the science of communication because both are a unifed whole and a link that supports public relations activities.
Hida, Ramdhania El, Fatimah, Fatimah
core
Expert Report for the UK Covid-19 Public Inquiry: Module 2B: Welsh Government core political and administrative decision-making in relation to the Covid-19 pandemic [PDF]
Expect Report for the UK Covid-19 Public Inquiry: Module 2B: Welsh Government core political and administrative decision-making in relation to the Covid-19 ...
Wincott, Daniel +1 more
core +6 more sources
The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic
Human Vaccines & Immunotherapeutics, 2022 Background Addressing COVID-19 vaccine hesitancy is key to ending the COVID-19 pandemic. Communication and media environments are potential drivers of vaccine hesitancy.
Hui Ouyang, Xiaohan Ma, Xiang Wu
doaj +1 more source
Journal of Community Service and Empowerment, 2023 The COVID-19 pandemic in Indonesia has resulted in high morbidity and mortality from COVID-19. Providing COVID-19 vaccination is one step to minimize the impact of COVID-19.
Ekorini Listiowati +6 more
doaj +1 more source
Journal of Primary Care & Community Health, 2021 Objectives: Arkansas COVID-19 vaccine uptake has been lower than the national average. This study examined associations between sociodemographic factors and COVID-19 vaccine hesitancy, fear of infection, and protection self-efficacy.
Pearl A. McElfish +5 more
doaj +1 more source
Vaccines, 2021 Understanding the public’s attitude towards COVID-19 vaccination and their acceptance could help facilitate the COVID-19 rollout. This study aimed to assess the acceptance and willingness to pay (WTP) for the COVID-19 vaccine among migrants in Shanghai ...
Kaiyi Han +7 more
doaj +1 more source
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial [PDF]
, 2021 Background A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy of the adenoviral vector vaccine, ChAdOx1 nCoV-19 (AZD1222), against this ...
Minassian, Angela M +34 more
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao +5 more
wiley +1 more source
COVID-19 vaccine development pipeline
, 2020 A COVID-19 vaccine development tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, that follows COVID-19 vaccine candidates as they progress through the development ...
Vaccine Centre
core +3 more sources
Predictors of COVID-19 vaccine hesitancy among Egyptian healthcare workers: a cross-sectional study
BMC Infectious Diseases, 2021 Background Coronavirus disease 2019 (COVID-19) vaccination has raised concerns about vaccine hesitancy in general and COVID-19 vaccine hesitancy in particular.
Rehab H. El-Sokkary +6 more
doaj +1 more source